Yahoo · Oct 6, 2026
Fortitude Doubles Down on Zcash Mining With $100M BITMAIN Commitment
Fortitude Mining Holdings signed a non-binding letter of intent with Bitmain Technologies, according to a Monday
HS
NASDAQ · HSCSW
HeartSciences Inc.
Healthcare · Medical - Devices
$0.07
Up+$0.00 (+0.15%)
Updated Oct 11, 2026, 2:47 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 191.88K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.04 – $0.12
- Volume
- 906
- Avg. volume
- 4.54K
Price performance · HSCSW
HSCSW price history
1M range · 10 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
HSCSW closed at $0.07 after 10 trading sessions, up 17.99% for the selected period.
- Last close
- $0.07
- Period change
- +17.99%
- Period low
- $0.04
- Period high
- $0.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $0.07 | $0.07 | $0.0681 | $0.0681 | 906 |
| Oct 8, 2026 | $0.0681 | $0.0681 | $0.068 | $0.068 | 9.84K |
| Oct 6, 2026 | $0.0995 | $0.0998 | $0.06 | $0.06 | 8.61K |
| Oct 5, 2026 | $0.0997 | $0.0997 | $0.0995 | $0.0995 | 12.55K |
| Oct 1, 2026 | $0.046 | $0.046 | $0.0459 | $0.0459 | 8.51K |
| Sep 22, 2026 | $0.0525 | $0.0549 | $0.0437 | $0.0437 | 5.37K |
| Sep 18, 2026 | $0.051 | $0.0538 | $0.0435 | $0.0537 | 26.57K |
| Sep 17, 2026 | $0.07 | $0.0949 | $0.0429 | $0.0429 | 32.81K |
| Sep 16, 2026 | $0.07 | $0.07 | $0.0503 | $0.06 | 3.38K |
| Sep 14, 2026 | $0.0599 | $0.06 | $0.0508 | $0.0577 | 2.91K |
Latest HSCSW news
The latest Smart Investors Daily articles mentioning HSCSW.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HSCSW research
Overview
Company profile and research snapshot.
Company profile
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Oct 6, 2026
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted 510(k) clearance (K260005) for its MyoVista® wavECGTM device as a 12-lead resting electrocardiograph. The clearance covers the
Yahoo · Sep 17, 2026
Former Hut 8 CEO To Lead Crypto Miner Fortitude
Former Hut 8 (NASDAQ: $HUT) Chief Executive Officer (CEO) Jaime Leverton has been appointed to lead cryptocurrency ...
Yahoo · Sep 15, 2026
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026 Commercial effort concentrated on the MyoVista Insights™ platform, with first US commercial agreements signed and selection as the AI-ECG delivery platform for a major European reference center Southlake, TX, Sept. 15, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Compan
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
